Somatic Disorders
Conference Coverage
Treatment adherence makes big impact in psychogenic nonepileptic seizures
HOUSTON - Patients with psychogenic nonepileptic seizures who stick with evidence-based treatment have significantly fewer seizures and have less...
Podcasts
Treating depression after TBI
Med/Psych Update
Evaluating the risk of sexually transmitted infections in mentally ill patients
Recommend screening for high-risk patients; consider adverse effects of STI treatmentSexually transmitted infections (STIs) continue to be a...
Savvy Psychopharmacology
Managing clozapine-induced neutropenia and agranulocytosis
Mr. S, age 43, has schizophrenia and been stable on clozapine for 6 years after several other antipsychotic regimens failed. Mr. S also has a...
Pearls
Assess and treat catatonia using this systematic approach
Catatonia is a neuropsychiatric condition with varying presentations that involve behavioral, motoric, cognitive, affective, and, occasionally,...
Med/Psych Update
How to assess and manage high cholesterol in patients with mental illness
Statins, lifestyle changes could reduce total cholesterol and cardiovascular risk High serum cholesterol is a leading cause of heart attack and...
Pearls
Consider Rx metformin to prevent metabolic syndrome
Many atypical antipsychotics, particularly clozapine and olanzapine, are associated with weight gain, insulin resistance, and metabolic syndrome....
Med/Psych Update
High-value intervention: Providing colorectal cancer screening
Cancer screening is an important example of secondary prevention—the aim being to detect disease at an early stage, when treatment can prevent...
Pearls
Take steps to relieve ataxia in patients with alcohol use disorder
Ataxia is a well-known complication of chronic alcohol abuse, which is attributed to degeneration of the cerebellar vermis. However, effective...
Video
Ataxia due to alcohol abuse
Out Of The Pipeline
Pimavanserin for psychosis in patients with Parkinson’s disease
Pimavanserin is a potent 5-HT2A inverse agonist and 5-HT2C inverse agonist, with 5-fold greater affinity for the 5-HT2A receptor.1...